FDA Brief

Warning letters Biologics

FDA warning letter to

Fresenius Kabi AG

Issued Sep 14, 2023Posted Sep 29, 2023Division of Biological Products Operations I

CGMP Deviations. We haven't summarized this letter yet. Read it on fda.gov.

Fresenius Kabi AG's FDA history

  1. Fresenius Kabi AG

    CGMP/QSR/Medical Devices/Adulterated

Full company page